Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Hyodeoxycholic acid (NSC 60672) has been used in trials studying the treatment of Hypercholesterolemia.
パッケージサイズ | 在庫状況 | 単価(税別) | |||
---|---|---|---|---|---|
サンプルについてお問い合わせ | |||||
50 mg | 在庫あり | ¥ 9,000 | |||
100 mg | 在庫あり | ¥ 12,500 | |||
1 mL * 10 mM (in DMSO) | 在庫あり | ¥ 13,000 |
説明 | Hyodeoxycholic acid (NSC 60672) has been used in trials studying the treatment of Hypercholesterolemia. |
ターゲット&IC50 | TGR5/GPCR19:31.6 µM(EC50) |
別名 | NSC 60672, α-Hyodeoxycholic Acid, HDCA |
分子量 | 392.57 |
分子式 | C24H40O4 |
CAS No. | 83-49-8 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 72 mg/mL (183.4 mM)
Ethanol: 72 mg/mL (183.4 mM)
H2O: < 1 mg/mL (insoluble or slightly soluble)
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Hyodeoxycholic acid 83-49-8 GPCR/G Protein Metabolism GPCR19 Endogenous Metabolite FXR NSC 60672 Inhibitor alpha-Hyodeoxycholic Acid inhibit TGR5 NSC60672 GPBAR1 G-protein coupled receptor 19 α-Hyodeoxycholic Acid HDCA a-Hyodeoxycholic Acid G protein-coupled Bile Acid Receptor 1 NSC-60672 inhibitor